abrdn Healthcare Opportunities Fund:THQ

    Manage Alerts

    Overview

    As of 12/20/2024

     Share
    Price
    NAVPremium/
    Discount
    Current$18.71$20.10-6.92%
    52 Wk Avg$20.25$21.88-7.44%
    52 Wk High$22.60$23.43-1.10%
    52 Wk Low$17.86$19.83-15.96%
    Regular Distribution TypeManaged Distribution
    Distribution Rate11.54%
    Distribution Amount$0.1800
    Distribution FrequencyMonthly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Fund’s investment objective is to seek current income and long-term capital appreciation. Under normal market conditions, the Fund expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity securities, debt securities, and pooled investment vehicles.

    Capital Structure

    As of 12/20/2024

    Total Investment Exposure:$1,056.257M
    Total Common Assets:$831.257M
    Common Shares Outstanding:41,356,058
    Leverage

    As of 12/20/2024

    Preferred Share Assets:
    Total Debt (USD): $225.000M
    Regulatory Leverage (USD): $225.000M
    Effective Leverage (USD): $225.000M
    Effective Leverage (%): 21.30%
    Annual Expense Ratios

    As of 9/30/2024

      Per Common Share
    Management FeesN/A
    Other Expenses:N/A
    Baseline Expense: N/A
    Interest Expense:N/A
    Total: 3.10%
    Fund Management

    Fund Sponsor
    abrdn Inc.

    Portfolio Managers
    Jason C. Akus

    Basics
    Category: Equity-Sector Equity
    Ticker: THQ
    NAV Ticker: XTHQX
    Average Daily Volume (shares): 137,549
    Average Daily Volume (USD): $2.768M
    Inception Date: 7/28/2014
    Inception Share Price: $20.00
    Inception NAV: $19.06
    Tender Offer: No
    Term: No
    Fiscal Year End: September 30
    Third Party Links & Reports

    Distributions

    As of 12/20/2024

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 9/30/2024
    -$0.0545
    Annualized Distribution Rate on NAV:
    As of 12/20/2024
    10.75%
    Total Return on NAV (12 months):
    As of 12/20/2024
    15.87%
    Avg. Portfolio Coupon:
    As of 12/20/2024
    4.00%
    Total % Portfolio Effectively Leveraged:
    As of 12/20/2024
    21.30%

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 12/20/2024

    PeriodAvg Discount
    6 Month-4.59%
    1 Year-7.44%
    3 Year-8.77%
    5 Year-7.90%
    Z-Score

    As of 12/20/2024

    PeriodZStat
    3 Month-1.93
    6 Month-1.30
    1 Year0.14
    Pricing History
    Date NAV Premium / Discount

    Performance

    Calendar Year Total Returns

    As of 11/30/2024
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    YTD26.59%10.58%34.33%19.16%
    2023-1.60%1.87%4.81%6.23%
    2022-17.48%-6.29%-10.73%-7.15%
    202133.48%22.64%22.39%17.58%
    202015.22%11.12%5.15%5.71%
    201922.66%22.02%26.64%22.38%
    20183.46%2.16%-12.35%-9.96%
    201721.87%19.83%18.18%12.88%
    2016-2.99%-4.63%17.45%14.67%
    2015-5.32%0.78%-15.98%-12.75%
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 11/30/2024
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Average Coupon:
    As of 12/20/2024
    4.00%
    Number of Holdings:
    As of 9/30/2024
    111
    Annual Portfolio Turnover:
    As of 9/30/2024
    43.00%
    Asset Allocation

    As of 9/30/2024

    Top Sectors

    As of 9/30/2024

    Sector%Portfolio
    Healthcare92.07%
    Defensive (Super Sector)92.07%
    Corporate (Super Sector)19.04%
    Corporate Bond17.13%
    Cash Equivalents (Super Sector)6.50%
    Cash Equivalents6.50%
    Real Estate6.41%
    Cyclical (Super Sector)6.41%
    Preferred Stock1.91%
    Top Holdings

    As of 9/30/2024

    HoldingValue% Portfolio
    Eli Lilly and Co$89.84M9.52%
    UnitedHealth Group Inc$89.66M9.50%
    AbbVie Inc$53.85M5.70%
    Johnson & Johnson$48.95M5.19%
    Thermo Fisher Scientific Inc$42.92M4.55%
    Merck & Co Inc$38.68M4.10%
    Abbott Laboratories$37.02M3.92%
    Intuitive Surgical Inc$32.81M3.48%
    Elevance Health Inc$28.90M3.06%
    Other Liability$-229.61M-24.33%
    Credit Quality

    As of 9/30/2024

    Maturity Breakdown

    As of 9/30/2024

    Country Allocation

    As of 9/30/2024

    Country% Portfolio
    United States - Equity97.63%
    United States - Fixed Income16.54%
    United Kingdom - Fixed Income0.59%
    Switzerland - Equity0.48%
    United Kingdom - Equity0.35%
    China - Equity0.01%
    Canada - Equity0.00%
    Netherlands - Equity0.00%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.

    NOTES:

    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. CEFConnect.com does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.

    E-2949862P-E0623W